Vitamin D Deficiency by Latitude: Why Your Geography Determines Your Dose

Vitamin D is the only nutrient that the human body can manufacture from sunlight. Specifically, ultraviolet B radiation between 290 and 315 nanometers strikes the skin, converts 7-dehydrocholesterol to previtamin D3, and triggers the hepatic and renal conversion to the active hormone 1,25-dihydroxyvitamin D. This synthesis is efficient when it can happen — but it depends on a variable most people never think about: the angle at which sunlight reaches the ground.

When the sun is high in the sky, UVB radiation passes through a thin column of atmosphere and arrives at the skin at the required wavelengths. When the sun is low — early morning, late afternoon, or anywhere in the northern hemisphere during winter months — UVB is filtered out by the longer atmospheric path. The exact threshold has been quantified: when the solar zenith angle exceeds approximately 60 degrees, vitamin D synthesis in the skin essentially stops, regardless of how long a person stays outside. This is the latitude problem, and it determines who can rely on sunlight and who cannot.

• Below 35° N/SYear-round synthesis possible. Examples: Los Angeles, Tokyo, Sydney, Cairo. Brief midday exposure typically sufficient.
• 35° – 50°Synthesis available roughly April–October. Examples: NYC, Madrid, Beijing, Seoul. Winter supplementation usually needed.
• Above 50°Synthesis available May–September only. Examples: London, Berlin, Vancouver, Stockholm. Sustained supplementation often required.

The Latitude Threshold

The foundational study on this was published in 1988 by Ann Webb and colleagues at Boston University. They measured cutaneous vitamin D synthesis at multiple latitudes across an entire year, comparing Boston (42°N), Edmonton (52°N), Los Angeles (34°N), and San Juan, Puerto Rico (18°N). The results revealed a clean latitudinal gradient.

Below 35° latitude, the sun reaches a sufficient zenith angle every day of the year. Vitamin D synthesis occurs whenever the skin is exposed to midday sun, and a few minutes of exposure on a fair-skinned individual produces a substantial dose. People living in this band — including most of the southern United States, the Mediterranean countries, the southern half of China and Japan, all of Australia, and most of Africa and Latin America — can reasonably depend on sunlight to maintain vitamin D status.

Between 35° and 50° latitude, the sun is high enough during summer months but drops below the synthesis threshold for several months in winter. The exact window depends on cloud cover, time of day, and skin pigmentation, but a useful approximation is that residents of New York, Madrid, Beijing, or Seoul have approximately seven months per year (April through October) of available synthesis and five months without. Stored vitamin D from summer exposure tides the body through autumn, but levels typically fall below recommended thresholds by February and remain low until April.

Above 50° latitude — Northern Europe, Canada north of the U.S. border, Northern Russia, southern South America — the situation is more severe. The available synthesis window narrows to four or five months. Even during summer, the angle of incidence is steep enough that synthesis efficiency is reduced. Residents of London, Berlin, Stockholm, or Vancouver who do not actively supplement spend the majority of the year in some degree of vitamin D insufficiency.

This is not a uniformly distributed health concern. It is a geographically determined one.

What Skin Pigmentation Does to the Calculation

Melanin in the skin absorbs UVB radiation. This is biologically protective — it reduces skin cancer risk and oxidative damage — but it also reduces vitamin D synthesis at a given level of sun exposure. The magnitude of this effect is substantial. People with very dark skin (Fitzpatrick types V and VI) typically produce roughly one-tenth as much vitamin D from equivalent UVB exposure as people with very fair skin (types I and II).

This evolutionary adaptation made sense in equatorial regions where UVB is abundant. It becomes a liability at higher latitudes where UVB is scarce. The result is that vitamin D deficiency is dramatically more common among people of African or South Asian descent living in northern climates than among lighter-skinned residents of the same regions. African Americans show vitamin D deficiency rates of approximately 70% in winter, compared with roughly 30% in non-Hispanic white Americans at the same latitudes.

For a fair-skinned individual at 40° N latitude, ten to fifteen minutes of midday summer sun on the face and arms produces roughly 1,000 IU of vitamin D — equivalent to most daily supplement doses. For a person with dark skin at the same latitude, the same exposure produces under 200 IU. Three to four times longer exposure is needed to reach equivalent synthesis, and even then, only during the active synthesis window.

What the Blood Levels Show

Vitamin D status is measured by serum 25-hydroxyvitamin D — the storage form that reflects total body status, not the active hormone. The reference ranges are debated, but a widely accepted framework places deficiency below 20 ng/mL (50 nmol/L), insufficiency at 20-30 ng/mL, and adequacy at 30 ng/mL or above. Some endocrinologists argue for a target of 40-60 ng/mL based on evidence linking these higher levels to improved bone, immune, and metabolic outcomes; others argue that the 30 ng/mL threshold is sufficient and that higher levels show diminishing returns.

The epidemiology reveals how widespread deficiency is. National data from the United States estimate that approximately 35% of adults are deficient by the strict 20 ng/mL threshold, and over 60% are below the 30 ng/mL adequacy threshold. Rates climb in winter months and are higher in northern states, in older adults, in people with darker skin, in people with obesity (vitamin D sequesters in adipose tissue and becomes less bioavailable), and in people who spend most of their time indoors.

The deficiency is consequential. The clearest associations are with bone health — vitamin D is essential for calcium absorption and bone mineralization, and severe deficiency causes rickets in children and osteomalacia in adults. The associations with cardiovascular disease, cancer, autoimmune disease, and infections are weaker but consistent enough that public health authorities increasingly recommend population-level supplementation in high-risk groups.

Where the VITAL Trial Lands

The largest randomized controlled trial of vitamin D supplementation to date is VITAL, published in the New England Journal of Medicine in 2019. The study enrolled 25,871 adults and randomized them to either 2,000 IU per day of vitamin D3 or placebo, with co-randomization for fish oil. The primary endpoints were major cardiovascular events and invasive cancer over a median 5.3 years of follow-up.

The headline result was negative. Neither primary endpoint reached statistical significance. The much-anticipated cancer and cardiovascular benefits of widespread vitamin D supplementation did not materialize at the population level.

The subgroup and secondary findings are more nuanced. Cancer mortality — distinct from incidence — was reduced by 17% in the vitamin D group, suggesting that supplementation may slow progression even if it does not prevent initial occurrence. People entering the trial with low baseline vitamin D showed more benefit than those with adequate status. Autoimmune disease incidence in a separate VITAL substudy was reduced by 22% over five years, a meaningful effect that has supported expanded use in populations at autoimmune risk.

The cleaner interpretation of VITAL is not that vitamin D supplementation is useless, but that benefits are concentrated in people who actually need the supplementation — those with low baseline levels — and that universal supplementation of an already-adequate population does not produce population-wide benefits.

Practical Recommendations by Geography

The dose recommendations that emerge from this body of evidence vary by latitude, season, skin pigmentation, age, and baseline level. Generalizable guidance:

For adults living below 35° latitude with moderate sun exposure, fair to medium skin, and no obesity, dietary intake plus typical incidental sunlight is often sufficient. Routine supplementation is reasonable but not mandatory. A daily intake of 600-800 IU from food and supplement sources is the conservative target.

For adults living between 35° and 50° latitude, year-round supplementation of 1,000-2,000 IU per day produces adequate serum levels in most people, with seasonal variation possible (lower doses in summer, higher in winter). People with darker skin, obesity, or limited sun exposure within this band may need 2,000-4,000 IU per day to maintain adequacy.

For adults above 50° latitude, sustained supplementation of 2,000 IU per day or higher is generally needed to maintain serum levels above 30 ng/mL through the winter months. Some endocrinologists routinely recommend 4,000 IU per day in this group, particularly during winter.

For adults of any latitude with documented deficiency (serum below 20 ng/mL), corrective doses of 4,000-6,000 IU per day for two to three months, followed by maintenance doses, are commonly prescribed.

Routine serum testing is not necessary for low-risk adults but should be considered for older adults, people with darker skin in northern climates, people with malabsorption conditions, people with osteoporosis or unexplained bone pain, and people with autoimmune conditions. Testing once and adjusting dose based on the result is more useful than testing repeatedly without intervention.

The broader point is that vitamin D, more than nearly any other nutrient, is determined by where you live and what you look like. Generic recommendations issued without reference to latitude and skin tone consistently undertreat the populations who need the most and overtreat those who need the least. The geography matters.

Sarah Chen is the Nutrition Editor at HealthKoLab. She is a Registered Dietitian Nutritionist with a Master's in Nutritional Science from UC Davis.